Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial – CNBC
In this article NTLA Follow your favorite stocksCREATE FREE ACCOUNT Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, USA. Spencer Grant | Universal Images Group | Getty Images Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition met its goals in a late-stage trial, marking a milestone for the field of gene…
